Loading...
XIDX
RSGK
Market cap54mUSD
Jan 30, Last price  
980.00IDR
Name

Kedoya Adyaraya Tbk PT

Chart & Performance

D1W1MN
XIDX:RSGK chart
P/E
22.95
P/S
2.07
EPS
42.69
Div Yield, %
1.12%
Shrs. gr., 5y
-14.59%
Rev. gr., 5y
9.15%
Revenues
441.07b
+18.12%
242,988,383,688284,703,789,856294,916,939,542435,196,072,386359,156,149,470373,399,870,743441,072,474,000
Net income
39.69b
+57.58%
12,722,869,1753,935,843,1182,615,905,33652,908,528,28126,179,899,83525,188,835,60439,692,367,000
CFO
81.80b
+190.29%
12,722,869,1753,417,830,74322,266,936,96685,540,650,68768,277,280,28728,180,613,02181,804,569,000
Dividend
Jun 24, 202411 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PT Kedoya Adyaraya Tbk owns and operates hospitals in Indonesia. The company provides healthcare services in various specialties, such as general surgery, orthopedic surgery, urology, cardiothoracic surgery, plastic surgery, neurosurgery, internist, nephrologist, endocrinologist & metabolic, obstetrics and gynecology specialist, cardiology, neurology, pulmonology, ophthalmologist, hyperbaric, pediatrician, acupuncture, medical rehabilitation, speech therapy, oral and maxillofacial, prosthodontics, dentists, psychiatrists, psychologists, nutritionists, and skin and venereal specialists, as well as medical services. As of December 31, 2021, it operated 2 hospitals with a total of 200 beds. The company was founded in 1990 and is headquartered in Jakarta Barat, Indonesia. PT Kedoya Adyaraya Tbk is a subsidiary of PT Sarana Meditama Metropolitan Tbk.
IPO date
Sep 08, 2021
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT